News tagged with tumor stage
Circulating tumor cells not linked to survival in newly diagnosed inflammatory breast cancer
The presence of circulating tumor cells in the blood appears to have no relationship to survival in women who have just been diagnosed with inflammatory breast cancer, according to new research from Fox Chase Cancer Center. ...
Dec 09, 2011 |
not rated yet |
0
BRCA2 genetic mutation associated with improved survival, chemotherapy response in ovarian cancer
Among women with a certain type of high-grade ovarian cancer, having BRCA2 genetic mutations, but not BRCA1, was associated with improved overall survival and improved response to chemotherapy, compared to women with BRCA ...
Oct 11, 2011 |
not rated yet |
0
|
New tool helps identify prostate cancer patients with highest risk of death
After a prostate cancer patient receives radiation treatment, his doctor carefully monitors the amount of prostate-specific antigen, or PSA, in his blood. An increase in PSA, called biochemical failure, is the first detectable ...
Oct 05, 2011 |
5 / 5 (2) |
0
Patients' underlying health linked to worse outcomes for melanoma, study finds
It's not how old but how frail patients are that can predict how well they will fare after a melanoma diagnosis. In fact, young patients in poor health may have worse outcomes than older patients in good shape.
Aug 30, 2011 |
5 / 5 (1) |
0
|
Small molecules shed light on cancer therapies
Patients suffering from an aggressive brain cancer will benefit from the results of a University of Illinois study that could advance the development of targeted gene therapies and improve prognosis.
Aug 22, 2011 |
not rated yet |
0
PET imaging determines malignancy in potential ovarian cancer cases
A study presented at SNM's 58th Annual Meeting may provide a new tool for detection of malignant-stage ovarian cancer. Researchers found that positron emission tomography and computed tomography (PET/CT), which images both ...
Jun 06, 2011 |
not rated yet |
0
Lymphocyte count indicates the prognosis of patients with renal cell carcinoma
Each year, kidney cancer is diagnosed in nearly 60,000 people in the U.S. Many of these patients undergo surgery to remove the affected kidney, but this procedure can be risky for the elderly and those who have other health ...
Jun 01, 2011 |
not rated yet |
0
|
Shave biopsy is a safe and acceptable method for initial evaluation of melanoma
A shave biopsy is a reasonably safe and accurate method for the initial diagnosis of melanoma, according to a study published in the April issue of the Journal of the American College of Surgeons. In the past, some physic ...
May 23, 2011 |
not rated yet |
0
Researchers discover that lymphocyte count indicates prognosis of patients with renal cell carcinoma
Each year, kidney cancer is diagnosed in nearly 60,000 people in the U.S. Many of these patients undergo surgery to remove the affected kidney, but this procedure can be risky for the elderly and those who have other health ...
May 18, 2011 |
not rated yet |
1
Research identifies patterns of CD24, a novel biomarker for non-small cell lung carcinomas
The May edition of the Journal of Thoracic Oncology features a study aimed to clarify expression patterns of a novel cancer biomarker, CD24, in non-small cell lung carcinomas (NSCLC) and to correlate the findings to clinic ...
May 05, 2010 |
not rated yet |
0
PET imaging response a prognostic factor after thoracic radiation therapy for lung cancer
A rapid decline in metabolic activity on a PET scan after radiation therapy for non-small cell lung cancer is correlated with good local tumor control, according to a study presented by researchers at Thomas Jefferson University ...
Nov 06, 2009 |
5 / 5 (1) |
0
Cancer researchers link DICER1 gene mutation to rare childhood cancer
Research published today in Science Express from the journal Science demonstrates the first definitive link between mutations in the gene DICER1 and cancer. By studying the patterns of DNA from 11 families with an unusua ...
Jun 25, 2009 |
not rated yet |
0
New universal breast cancer marker predicts recurrence and clinical outcome
Reporting online in the American Journal of Pathology, researchers from the Kimmel Cancer Center at Jefferson have implicated the loss of a stromal protein called caveolin-1 as a major new prognostic factor in patients with b ...
May 06, 2009 |
not rated yet |
0
Neutralizing tumor growth in embryonic stem cell therapy
Researchers at the Hebrew University of Jerusalem have discovered a method to potentially eliminate the tumor-risk factor in utilizing human embryonic stem cells.
May 06, 2009 |
1 / 5 (1) |
0
New staging technique might save bladders in some bladder cancer patients
Pathologists today reported encouraging results from a new technique to increase the accuracy of staging bladder cancer tumors that could reduce the need to remove bladders from some patients.
Mar 09, 2009 |
not rated yet |
1
- Pages: 1
